Streetbeat News

Stock Prices

HALO

Halozyme Therapeutics (NYSE:HALO) has seen a 3.77% increase in its short percent of float, now at 10.74%. This is higher than its peers' average of 5.85%. It would take traders 7.75 days to cover their short positions. Increased short interest can indicate bearish sentiment but may also present bullish opportunities.

Portfolio Pulse from Benzinga Insights

September 13, 2024 | 7:00 pm

ULTA

Ulta Beauty's short interest has increased by 44.12%, with 3.23 million shares sold short, representing 8.82% of its float. This is below the peer group average of 12.73%. The rise in short interest suggests a bearish sentiment, but it doesn't guarantee a price drop.

Portfolio Pulse from Benzinga Insights

September 13, 2024 | 7:00 pm

COTY

Coty (NYSE:COTY) has been analyzed by 9 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $12.89, a decrease from the previous $13.61. Analysts have adjusted their ratings and price targets, reflecting their views on Coty's market position. Coty is a global beauty company with a focus on fragrance and color cosmetics, and it faces challenges with high debt levels despite strong financial management indicators.

Portfolio Pulse from Benzinga Insights

September 13, 2024 | 7:00 pm

ETHUSD

Ethereum's price has increased by 3.1% in the last 24 hours, continuing a positive trend with an 8% gain over the past week. Despite a 42% drop in trading volume, the circulating supply has slightly increased. Ethereum's market cap is ranked #2 at $291.20 billion.

Portfolio Pulse from Benzinga Insights

September 13, 2024 | 7:00 pm

TIL

Instil Bio shares surged after Baird maintained an Outperform rating and significantly raised its price target from $32 to $180.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 6:59 pm

AVIR

Atea Pharmaceuticals' COVID-19 treatment, bemnifosbuvir, failed to meet the primary endpoint in a Phase 3 trial, attributed to the evolving nature of the virus and milder disease trends. Despite this setback, Atea continues to focus on hepatitis C treatments, showing promising results in a Phase 2 study. AVIR stock rose 3.41% following the news.

Portfolio Pulse from Vandana Singh

September 13, 2024 | 6:53 pm

BLD

BLDR

TOL

Homebuilder stocks are experiencing a rise in trading. This could be due to various market factors influencing the housing sector.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 6:51 pm

MAT

Mattel's shares experienced significant trading volume following an 800,000 block trade at $19 per share. This large transaction could indicate institutional interest or a strategic move by investors.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 6:51 pm

BLD

BLDR

DHI

HOV

IBP

LGIH

TOL

Z

ZG

Housing stocks and homebuilders are experiencing a rise in share prices due to a drop in yields and anticipation of rate cuts.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 6:51 pm

NATR

Canaccord Genuity analyst Susan Anderson initiated coverage on Nature’s Sunshine Products (NASDAQ:NATR) with a Buy rating and a price target of $18. The company is expected to achieve a 15% adjusted EBITDA margin by FY28 through digital sector investments, international expansion, and product innovation. NATR shares rose 6.26% to $14.08.

Portfolio Pulse from Nabaparna Bhattacharya

September 13, 2024 | 6:51 pm